Application 090833
- Type
- ANDA
- Sponsor
- WOCKHARDT LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | TABLET;ORAL | 18.75MG;200MG;75MG | No | No |
| 002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | TABLET;ORAL | 25MG;200MG;100MG | No | No |
| 003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | TABLET;ORAL | 31.25MG;200MG;125MG | No | No |
| 004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | TABLET;ORAL | 37.5MG;200MG;150MG | No | No |
| 005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | TABLET;ORAL | 50MG;200MG;200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090833-001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | 18.75MG;200MG;75MG | TABLET / ORAL | 2012-11-20 | ||
| A090833-002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | 25MG;200MG;100MG | TABLET / ORAL | 2012-11-20 | ||
| A090833-003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | 31.25MG;200MG;125MG | TABLET / ORAL | 2012-11-20 | ||
| A090833-004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | 37.5MG;200MG;150MG | TABLET / ORAL | 2012-11-20 | ||
| A090833-005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA; ENTACAPONE; LEVODOPA | 50MG;200MG;200MG | TABLET / ORAL | 2012-11-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2021-03-12 10:30 UTC | 2021-03 | A090833-001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 18.75MG;200MG;75MG | TABLET / ORAL | 2012-11-20 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090833-002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 25MG;200MG;100MG | TABLET / ORAL | 2012-11-20 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090833-003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 31.25MG;200MG;125MG | TABLET / ORAL | 2012-11-20 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090833-004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 37.5MG;200MG;150MG | TABLET / ORAL | 2012-11-20 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A090833-005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 50MG;200MG;200MG | TABLET / ORAL | 2012-11-20 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090833-001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 18.75MG;200MG;75MG | TABLET / ORAL | 2012-11-20 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090833-002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 25MG;200MG;100MG | TABLET / ORAL | 2012-11-20 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090833-003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 31.25MG;200MG;125MG | TABLET / ORAL | 2012-11-20 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090833-004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 37.5MG;200MG;150MG | TABLET / ORAL | 2012-11-20 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A090833-005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 50MG;200MG;200MG | TABLET / ORAL | 2012-11-20 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090833-001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 18.75MG;200MG;75MG | TABLET / ORAL | 2012-11-20 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090833-002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 25MG;200MG;100MG | TABLET / ORAL | 2012-11-20 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090833-003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 31.25MG;200MG;125MG | TABLET / ORAL | 2012-11-20 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090833-004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 37.5MG;200MG;150MG | TABLET / ORAL | 2012-11-20 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A090833-005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 50MG;200MG;200MG | TABLET / ORAL | 2012-11-20 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A090833-001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 18.75MG;200MG;75MG | TABLET / ORAL | 2012-11-20 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A090833-002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 25MG;200MG;100MG | TABLET / ORAL | 2012-11-20 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A090833-003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 31.25MG;200MG;125MG | TABLET / ORAL | 2012-11-20 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A090833-004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 37.5MG;200MG;150MG | TABLET / ORAL | 2012-11-20 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A090833-005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 50MG;200MG;200MG | TABLET / ORAL | 2012-11-20 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A090833-001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 18.75MG;200MG;75MG | TABLET / ORAL | 2012-11-20 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A090833-002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 25MG;200MG;100MG | TABLET / ORAL | 2012-11-20 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A090833-003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 31.25MG;200MG;125MG | TABLET / ORAL | 2012-11-20 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A090833-004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 37.5MG;200MG;150MG | TABLET / ORAL | 2012-11-20 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A090833-005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 50MG;200MG;200MG | TABLET / ORAL | 2012-11-20 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A090833-001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 18.75MG;200MG;75MG | TABLET / ORAL | AB | 2012-11-20 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A090833-002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 25MG;200MG;100MG | TABLET / ORAL | AB | 2012-11-20 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A090833-003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 31.25MG;200MG;125MG | TABLET / ORAL | AB | 2012-11-20 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A090833-004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 37.5MG;200MG;150MG | TABLET / ORAL | AB | 2012-11-20 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | A090833-005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 50MG;200MG;200MG | TABLET / ORAL | AB | 2012-11-20 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090833-001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 18.75MG;200MG;75MG | TABLET / ORAL | 2012-11-20 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090833-002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 25MG;200MG;100MG | TABLET / ORAL | 2012-11-20 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090833-003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 31.25MG;200MG;125MG | TABLET / ORAL | 2012-11-20 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090833-004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 37.5MG;200MG;150MG | TABLET / ORAL | 2012-11-20 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090833-005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 50MG;200MG;200MG | TABLET / ORAL | 2012-11-20 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A090833-001 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 18.75MG;200MG;75MG | TABLET / ORAL | 2012-11-20 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A090833-002 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 25MG;200MG;100MG | TABLET / ORAL | 2012-11-20 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A090833-003 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 31.25MG;200MG;125MG | TABLET / ORAL | 2012-11-20 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A090833-004 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 37.5MG;200MG;150MG | TABLET / ORAL | 2012-11-20 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A090833-005 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 50MG;200MG;200MG | TABLET / ORAL | 2012-11-20 | 1c564ffb4f44… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | A090833-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A090833-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A090833-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A090833-004 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A090833-005 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA, LEVODOPA AND ENTACAPONE | Rising Pharma Holdings, Inc. | 2f8e82d7-6baf-456a-b8c3-4fda6e317902 | 2026-04-08 | Warnings, Adverse reactions | CARBIDOPA, LEVODOPA AND ENTACAPONE |
| Carbidopa, Levodopa and Entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Macleods Pharmaceuticals Limited | f0d9d7a8-1d06-4119-b2bc-42b3ec08d45b | 2026-04-08 | Warnings, Adverse reactions | Carbidopa, Levodopa and Entacapone |
| carbidopa, levodopa and entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Alembic Pharmaceuticals Inc. | 9d4e886e-edec-471d-b619-bf4828a6b7ce | 2026-03-31 | Warnings, Adverse reactions | carbidopa, levodopa and entacapone |
| carbidopa, levodopa and entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Alembic Pharmaceuticals Limited | 9ff83838-b7d0-4eec-98f2-fcc85789a189 | 2026-02-17 | Warnings, Adverse reactions | carbidopa, levodopa and entacapone |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 9299 | ORIG | 2012-12-18 |